āSHIBIO
āshibio creates treatments for rare bone and connective tissue ailments, potentially preventing symptoms or slowing their course.
āSHIBIO
Social Links:
Industry:
Biotechnology Medical Device Therapeutics
Founded:
2022-01-01
Address:
Brisbane, California, United States
Country:
United States
Website Url:
http://www.ashibio.com
Total Employee:
1+
Status:
Active
Total Funding:
40 M USD
Current Advisors List
Investors List
Agent Capital
Agent Capital investment in Series A - āshibio
MPM Capital
MPM Capital investment in Series A - āshibio
Mirae Asset Venture Investment
Mirae Asset Venture Investment investment in Series A - āshibio
YK Bioventures
YK Bioventures investment in Series A - āshibio
Official Site Inspections
http://www.ashibio.com
- Host name: 6.74.215.35.bc.googleusercontent.com
- IP address: 35.215.74.6
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "āshibio"
ashibio
He serves as Chairman of a number of portfolio company boards including Aktis Oncology, ashibio, Crossbow Therapeutics and is a director on the boards of AstronauTx, Firefly Biologics and Tetherex Pharmaceuticals. He previously …See details»
ASHIBIO, A World Intellectual Property Organization Trademark of ...
ASHIBIO is a WIPO trademark and brand of ashibio, Inc., 2000 Sierra Point Parkway, Suite 701, Brisbane CA 94005,UNITED STATES. This trademark was filed to WIPO on Thursday, June …See details»
AshiBio Company Profile 2024: Valuation, Funding & Investors
AshiBio General Information Description. Developer of novel therapies intended for patients with rare bone and connective tissue disorders. The company prevents the onset of symptoms or …See details»
AshiBio - Products, Competitors, Financials, Employees, …
Ashibio licensed from Gilead Sciences an antibody called andecaliximab that targets the MMP-9 gene, mutations in which appeared protective in a notable case study . The company plans to …See details»
Org Chart Ashibio - The Official Board
Organizational Chart of Ashibio. Ashibio www.ashibio.com +1 617 425 9200; Add an executive. Ashibio News . Anything missing? We search for you. Print or download . Board. N-1. N-2 . …See details»
āshibio - Crunchbase Company Profile & Funding
āshibio is a privately held biotechnology business exploring innovative therapies to treat bone and connective tissue ailments.See details»
āshibio Raises $40M in Seed and Series A Financing to Advance …
Jun 20, 2024 For more information, visit www.ashibio.com. About MPM BioImpact MPM BioImpact is a world-leading biotechnology investment firm with over 30 years of expertise …See details»
āshibio - VentureRadar
Ashibio is a biotechnology company that specializes in developing a pipeline of novel therapeutics for the treatment of bone and connective tissue disorders. The company is advancing several …See details»
āshibio: Bone and Connective Tissue Disease Research
ā shi Derived from the word aasha which means hope, joy, blessing ā shibio is developing novel therapies for patients with rare bone and connective tissue disorders that have the potential to …See details»
Organigramme Ashibio - The Official Board
Organizational Chart of Ashibio. Ashibio www.ashibio.com +1 617 425 9200; Ajouter un décideur. Ashibio Actualités . Un manquant? Nous le cherchons. Imprimer ou télécharger . Conseil. N-1. …See details»
āshibio Company Profile | Management and Employees List
Www.ashibio.com . āshibio Profile and History. shibio is a privately held biotechnology company developing a pipeline of novel therapeutics for the treatment of bone and connective tissue …See details»
Ashibio - Company Profile - Tracxn
Oct 31, 2024 Ashibio ranks 25th among 77 active competitors. 16 of its competitors are funded while 17 have exited. Overall, Ashibio and its competitors have raised over $892M in funding …See details»
Series A - āshibio - 2024-06-20 - Crunchbase Funding Round Profile
Jun 20, 2024 Organization Name . āshibio . Announced Date Jun 20, 2024; Closed On Date Jun 20, 2024; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . $40M. …See details»
āshibio Raises $40M in Seed and Series A Financing to Advance …
BRISBANE, Calif., June 20, 2024--āshibio, with a focus on bone and connective tissue disorders, exited stealth mode today with $40 million in seed and Series A financing.See details»
āshibio, Inc - LinkedIn
āshibio, Inc | 221 followers on LinkedIn. āshibio is developing novel therapies for patients with rare bone and connective tissue disorders that have the potential to prevent the onset of ...See details»
āshibio Announces Appointment of Dipal Doshi, CEO of Entrada ...
BRISBANE, Calif. (Sept. 17, 2024) – āshibio, a privately held, clinical-stage biotechnology company developing novel therapeutics for the treatment of bone and connective tissue …See details»
ASHIBIO Trademark of ashibio, Inc.. Serial Number: 97736990 ...
Jun 26, 2024 TrademarkElite is the U.S. #1 Trademark Search and Registration Service :: ASHIBIO is a trademark and brand of ashibio, Inc., Brisbane, CA . This trademark application …See details»
āshibio: Bone And Connective Tissue Disorder Therapy Company …
Jun 25, 2024 āshibio, a privately held biotechnology company developing novel therapeutics for treating bone and connective tissue disorders, exited stealth mode with $40 million in seed …See details»
Āshibio Raises $40 Million to Advance Therapies for ... - Global …
Jun 20, 2024 Rare Daily Staff. Āshibio emerged from stealth mode with $40 million in seed and series A financing to advance therapies for bone and connective tissue disorders.See details»
āshibio - Overview, News & Similar companies | ZoomInfo.com
View āshibio (www.ashibio.com) location in California, United States , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»